chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Chest X-ray abnormal, Chest discomfort, Chest pain, Chills
Clinical narrative: Shortness of breath   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 61y.o. male with PMHx of HTN, HFpEF, a-flutter on Xarelto, CAD, bipolar disorder, schizophrenia, OSA, hx of DVT who presented to ED on 12/27 with shortness of breath and chest pain x 1 day. Patient reports his symptoms started yesterday evening. Admits to nonproductive cough and L-sided chest discomfort as well. Admits to fever, chills. Patient denies sick contacts. He has received two COVID-19 vaccines but not his booster. Denies recent travel. Denies abdominal pain, nausea, vomiting, diarrhea, constipation. Patient also endorses worsening swelling of his bilateral lower extremities as well as orthopnea. Most recent echo 9/2021 with EF 60%, abnormal LV diastolic function. Patient states he takes all of his medications regularly and has not missed a dose of his diuretics.    In the ED, vitals as follows: BP 119/75, HR 116, RR 18, T 101.4, SpO2 82% on RA. On exam, patient ill appearing and in respiratory distress with tachypnea and accessory muscle use. Patient initially placed on 6L NC, later placed on BiPAP with improvement in oxygen saturation. Labs remarkable for Hgb 8.0, K 3.1, Cr 1.38, alk phos 241, CRP 8.1, LDH 440, D-dimer 900, Mg 1.5, BNP 599. EKG demonstrated a-fib with RVR, troponin 0.59 -> 0.58. COVID-19 positive, flu/RSV negative. CXR with pulmonary edema and small R pleural effusion. Patient was given IV Lasix 40mg x 1, Cardizem 10mg x 1, and started on a Cardizem gtt with good response. Patient started on heparin gtt. He will be admitted to PCU for further management of COVID-19/CHF exacerbation with consults to infectious disease and cardiology.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Dyspnoea, Echocardiogram abnormal, Ejection fraction normal
Clinical narrative: Shortness of breath   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 61y.o. male with PMHx of HTN, HFpEF, a-flutter on Xarelto, CAD, bipolar disorder, schizophrenia, OSA, hx of DVT who presented to ED on 12/27 with shortness of breath and chest pain x 1 day. Patient reports his symptoms started yesterday evening. Admits to nonproductive cough and L-sided chest discomfort as well. Admits to fever, chills. Patient denies sick contacts. He has received two COVID-19 vaccines but not his booster. Denies recent travel. Denies abdominal pain, nausea, vomiting, diarrhea, constipation. Patient also endorses worsening swelling of his bilateral lower extremities as well as orthopnea. Most recent echo 9/2021 with EF 60%, abnormal LV diastolic function. Patient states he takes all of his medications regularly and has not missed a dose of his diuretics.    In the ED, vitals as follows: BP 119/75, HR 116, RR 18, T 101.4, SpO2 82% on RA. On exam, patient ill appearing and in respiratory distress with tachypnea and accessory muscle use. Patient initially placed on 6L NC, later placed on BiPAP with improvement in oxygen saturation. Labs remarkable for Hgb 8.0, K 3.1, Cr 1.38, alk phos 241, CRP 8.1, LDH 440, D-dimer 900, Mg 1.5, BNP 599. EKG demonstrated a-fib with RVR, troponin 0.59 -> 0.58. COVID-19 positive, flu/RSV negative. CXR with pulmonary edema and small R pleural effusion. Patient was given IV Lasix 40mg x 1, Cardizem 10mg x 1, and started on a Cardizem gtt with good response. Patient started on heparin gtt. He will be admitted to PCU for further management of COVID-19/CHF exacerbation with consults to infectious disease and cardiology.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Fibrin D dimer, Haemoglobin decreased, Influenza A virus test negative, Influenza B virus test
Clinical narrative: Shortness of breath   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 61y.o. male with PMHx of HTN, HFpEF, a-flutter on Xarelto, CAD, bipolar disorder, schizophrenia, OSA, hx of DVT who presented to ED on 12/27 with shortness of breath and chest pain x 1 day. Patient reports his symptoms started yesterday evening. Admits to nonproductive cough and L-sided chest discomfort as well. Admits to fever, chills. Patient denies sick contacts. He has received two COVID-19 vaccines but not his booster. Denies recent travel. Denies abdominal pain, nausea, vomiting, diarrhea, constipation. Patient also endorses worsening swelling of his bilateral lower extremities as well as orthopnea. Most recent echo 9/2021 with EF 60%, abnormal LV diastolic function. Patient states he takes all of his medications regularly and has not missed a dose of his diuretics.    In the ED, vitals as follows: BP 119/75, HR 116, RR 18, T 101.4, SpO2 82% on RA. On exam, patient ill appearing and in respiratory distress with tachypnea and accessory muscle use. Patient initially placed on 6L NC, later placed on BiPAP with improvement in oxygen saturation. Labs remarkable for Hgb 8.0, K 3.1, Cr 1.38, alk phos 241, CRP 8.1, LDH 440, D-dimer 900, Mg 1.5, BNP 599. EKG demonstrated a-fib with RVR, troponin 0.59 -> 0.58. COVID-19 positive, flu/RSV negative. CXR with pulmonary edema and small R pleural effusion. Patient was given IV Lasix 40mg x 1, Cardizem 10mg x 1, and started on a Cardizem gtt with good response. Patient started on heparin gtt. He will be admitted to PCU for further management of COVID-19/CHF exacerbation with consults to infectious disease and cardiology.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Left ventricular dysfunction, Orthopnoea, Peripheral swelling, Pleural effusion
Clinical narrative: Shortness of breath   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 61y.o. male with PMHx of HTN, HFpEF, a-flutter on Xarelto, CAD, bipolar disorder, schizophrenia, OSA, hx of DVT who presented to ED on 12/27 with shortness of breath and chest pain x 1 day. Patient reports his symptoms started yesterday evening. Admits to nonproductive cough and L-sided chest discomfort as well. Admits to fever, chills. Patient denies sick contacts. He has received two COVID-19 vaccines but not his booster. Denies recent travel. Denies abdominal pain, nausea, vomiting, diarrhea, constipation. Patient also endorses worsening swelling of his bilateral lower extremities as well as orthopnea. Most recent echo 9/2021 with EF 60%, abnormal LV diastolic function. Patient states he takes all of his medications regularly and has not missed a dose of his diuretics.    In the ED, vitals as follows: BP 119/75, HR 116, RR 18, T 101.4, SpO2 82% on RA. On exam, patient ill appearing and in respiratory distress with tachypnea and accessory muscle use. Patient initially placed on 6L NC, later placed on BiPAP with improvement in oxygen saturation. Labs remarkable for Hgb 8.0, K 3.1, Cr 1.38, alk phos 241, CRP 8.1, LDH 440, D-dimer 900, Mg 1.5, BNP 599. EKG demonstrated a-fib with RVR, troponin 0.59 -> 0.58. COVID-19 positive, flu/RSV negative. CXR with pulmonary edema and small R pleural effusion. Patient was given IV Lasix 40mg x 1, Cardizem 10mg x 1, and started on a Cardizem gtt with good response. Patient started on heparin gtt. He will be admitted to PCU for further management of COVID-19/CHF exacerbation with consults to infectious disease and cardiology.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Pulmonary oedema, Pyrexia, Respiratory distress, Respiratory syncytial virus test negative
Clinical narrative: Shortness of breath   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 61y.o. male with PMHx of HTN, HFpEF, a-flutter on Xarelto, CAD, bipolar disorder, schizophrenia, OSA, hx of DVT who presented to ED on 12/27 with shortness of breath and chest pain x 1 day. Patient reports his symptoms started yesterday evening. Admits to nonproductive cough and L-sided chest discomfort as well. Admits to fever, chills. Patient denies sick contacts. He has received two COVID-19 vaccines but not his booster. Denies recent travel. Denies abdominal pain, nausea, vomiting, diarrhea, constipation. Patient also endorses worsening swelling of his bilateral lower extremities as well as orthopnea. Most recent echo 9/2021 with EF 60%, abnormal LV diastolic function. Patient states he takes all of his medications regularly and has not missed a dose of his diuretics.    In the ED, vitals as follows: BP 119/75, HR 116, RR 18, T 101.4, SpO2 82% on RA. On exam, patient ill appearing and in respiratory distress with tachypnea and accessory muscle use. Patient initially placed on 6L NC, later placed on BiPAP with improvement in oxygen saturation. Labs remarkable for Hgb 8.0, K 3.1, Cr 1.38, alk phos 241, CRP 8.1, LDH 440, D-dimer 900, Mg 1.5, BNP 599. EKG demonstrated a-fib with RVR, troponin 0.59 -> 0.58. COVID-19 positive, flu/RSV negative. CXR with pulmonary edema and small R pleural effusion. Patient was given IV Lasix 40mg x 1, Cardizem 10mg x 1, and started on a Cardizem gtt with good response. Patient started on heparin gtt. He will be admitted to PCU for further management of COVID-19/CHF exacerbation with consults to infectious disease and cardiology.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Tachypnoea, Troponin increased, Use of accessory respiratory muscles
Clinical narrative: Shortness of breath   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 61y.o. male with PMHx of HTN, HFpEF, a-flutter on Xarelto, CAD, bipolar disorder, schizophrenia, OSA, hx of DVT who presented to ED on 12/27 with shortness of breath and chest pain x 1 day. Patient reports his symptoms started yesterday evening. Admits to nonproductive cough and L-sided chest discomfort as well. Admits to fever, chills. Patient denies sick contacts. He has received two COVID-19 vaccines but not his booster. Denies recent travel. Denies abdominal pain, nausea, vomiting, diarrhea, constipation. Patient also endorses worsening swelling of his bilateral lower extremities as well as orthopnea. Most recent echo 9/2021 with EF 60%, abnormal LV diastolic function. Patient states he takes all of his medications regularly and has not missed a dose of his diuretics.    In the ED, vitals as follows: BP 119/75, HR 116, RR 18, T 101.4, SpO2 82% on RA. On exam, patient ill appearing and in respiratory distress with tachypnea and accessory muscle use. Patient initially placed on 6L NC, later placed on BiPAP with improvement in oxygen saturation. Labs remarkable for Hgb 8.0, K 3.1, Cr 1.38, alk phos 241, CRP 8.1, LDH 440, D-dimer 900, Mg 1.5, BNP 599. EKG demonstrated a-fib with RVR, troponin 0.59 -> 0.58. COVID-19 positive, flu/RSV negative. CXR with pulmonary edema and small R pleural effusion. Patient was given IV Lasix 40mg x 1, Cardizem 10mg x 1, and started on a Cardizem gtt with good response. Patient started on heparin gtt. He will be admitted to PCU for further management of COVID-19/CHF exacerbation with consults to infectious disease and cardiology.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute kidney injury, Acute respiratory distress syndrome, Acute respiratory failure, Anaemia, Anticoagulant therapy
Clinical narrative: Hospitalized (1.6.22 - present - currently in ICU);  COVID-19 positive (1.6.22);  fully vaccinated (no booster) Admission date - 1.6.22:  Brief history and medical decision making: 76 y/o F with PMHx of HFpEF, rheumatic fever s/p mechanical MV replacement on warfarin, CAD s/p CABG, CKD3, COPD who presented with worsening SOB and hypoxia in setting of positive COVID test 10 days PTA. She is admitted for acute hypoxic respiratory failure. Also found to have AKI on CKD3 and supratherapeutic INR. Patient's SOB improving with placement on HFNC. Will continue dexamethasone. Hold on remdesivir as pt received monoclonal antibody 2 days PTA and has eGFR < 30. Continue HFNC, wean as tolerated. Supportive care. Give gentle hydration and monitor renal function. Pt given vitamin K in ED, monitor INR. Hold warfarin but plan to resume once INR is at goal range of 2.5-3.5. ASSESSMENT / PLAN: Patient is a 76 y.o. female with a PMHx significant for rheumatic fever s/p mechanical mitral valve replacement on warfarin, HFpEF diastolic dysfunction, CKD III, CABGx1, CAD, HLD, HTN, COPD, CVA, essential tremor, microcytic anemia, hypothyroidism who presents with acute hypoxic respiratory failure in the setting of worsening SOB after positive Covid test 10 days ago.   AHRF Covid-19 pneumonia COPD Exacerbation Worsening SOB, dyspnea and cough, O2 sat 50% on home pulse ox today. Wheezing on exam. satting 91% on 30 L HFNC 60% FIO2.   Plan: -Decadron 6 mg x10 days -O2 supplementation O2 sat goal 90-904% -Albuterol breathing treatment now then 2 puff q 6 -Home Symbicort BID -Continuous pulse ox, tele -Tessalon for cough, saline nasal spray  -If significant O2 desaturation, obtain repeat CXR, D-dimer, consider CTA Progress Note - 1.18.22:  (sedated and intubated) Principal Problem / Chief Complaint Respiratory failure with hypoxia Admitted: 1/6/2022 11:05 AM Length of Stay: 12 days.  Assessment and Plan Patient is a 76 y.o. female PMHx notable for HFpEF, rheumatic fever status post mechanical mitral valve, COPD, CKDIII, CAD s/p CABG x1, hypothyroidism who is admitted to the MICU for further management of acute hypoxic respiratory failure secondary to COVID 19 pneumonia and ARDS.  #  AHRF secondary to COVID-19 pneumonia Hx COPD Symptom onset 12/25, tested positive on 12/26, admitted on 01/06 and intubated 1/10.  Status post monoclonal antibodies on 01/04.  Vaccinated x2 but without booster.  Bronchoscopy with BAL performed 1/10. Negative for legionella and strep. Cultures NGTD. Plan:  o Tapering solumedrol, 30mg x3d (d2) o Lung protective ventilation; ARDS protocol o Completed 5 days Zosyn course o Continue COPD treatment:  Albuterol every 6 hours, Symbicort twice a day, Spiriva daily o Diurese to goal net negative 1L- Lasix 80mg TID o Renal function stable # Leukocytosis  WBC remains elevated but stable.Afebrile overnight with stable map. Continue to watch
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anticoagulation drug level above therapeutic, Blood creatinine increased, Blood lactic acid, Blood pressure decreased, Bronchoalveolar lavage
Clinical narrative: Hospitalized (1.6.22 - present - currently in ICU);  COVID-19 positive (1.6.22);  fully vaccinated (no booster) Admission date - 1.6.22:  Brief history and medical decision making: 76 y/o F with PMHx of HFpEF, rheumatic fever s/p mechanical MV replacement on warfarin, CAD s/p CABG, CKD3, COPD who presented with worsening SOB and hypoxia in setting of positive COVID test 10 days PTA. She is admitted for acute hypoxic respiratory failure. Also found to have AKI on CKD3 and supratherapeutic INR. Patient's SOB improving with placement on HFNC. Will continue dexamethasone. Hold on remdesivir as pt received monoclonal antibody 2 days PTA and has eGFR < 30. Continue HFNC, wean as tolerated. Supportive care. Give gentle hydration and monitor renal function. Pt given vitamin K in ED, monitor INR. Hold warfarin but plan to resume once INR is at goal range of 2.5-3.5. ASSESSMENT / PLAN: Patient is a 76 y.o. female with a PMHx significant for rheumatic fever s/p mechanical mitral valve replacement on warfarin, HFpEF diastolic dysfunction, CKD III, CABGx1, CAD, HLD, HTN, COPD, CVA, essential tremor, microcytic anemia, hypothyroidism who presents with acute hypoxic respiratory failure in the setting of worsening SOB after positive Covid test 10 days ago.   AHRF Covid-19 pneumonia COPD Exacerbation Worsening SOB, dyspnea and cough, O2 sat 50% on home pulse ox today. Wheezing on exam. satting 91% on 30 L HFNC 60% FIO2.   Plan: -Decadron 6 mg x10 days -O2 supplementation O2 sat goal 90-904% -Albuterol breathing treatment now then 2 puff q 6 -Home Symbicort BID -Continuous pulse ox, tele -Tessalon for cough, saline nasal spray  -If significant O2 desaturation, obtain repeat CXR, D-dimer, consider CTA Progress Note - 1.18.22:  (sedated and intubated) Principal Problem / Chief Complaint Respiratory failure with hypoxia Admitted: 1/6/2022 11:05 AM Length of Stay: 12 days.  Assessment and Plan Patient is a 76 y.o. female PMHx notable for HFpEF, rheumatic fever status post mechanical mitral valve, COPD, CKDIII, CAD s/p CABG x1, hypothyroidism who is admitted to the MICU for further management of acute hypoxic respiratory failure secondary to COVID 19 pneumonia and ARDS.  #  AHRF secondary to COVID-19 pneumonia Hx COPD Symptom onset 12/25, tested positive on 12/26, admitted on 01/06 and intubated 1/10.  Status post monoclonal antibodies on 01/04.  Vaccinated x2 but without booster.  Bronchoscopy with BAL performed 1/10. Negative for legionella and strep. Cultures NGTD. Plan:  o Tapering solumedrol, 30mg x3d (d2) o Lung protective ventilation; ARDS protocol o Completed 5 days Zosyn course o Continue COPD treatment:  Albuterol every 6 hours, Symbicort twice a day, Spiriva daily o Diurese to goal net negative 1L- Lasix 80mg TID o Renal function stable # Leukocytosis  WBC remains elevated but stable.Afebrile overnight with stable map. Continue to watch
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bronchoscopy, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chronic kidney disease
Clinical narrative: Hospitalized (1.6.22 - present - currently in ICU);  COVID-19 positive (1.6.22);  fully vaccinated (no booster) Admission date - 1.6.22:  Brief history and medical decision making: 76 y/o F with PMHx of HFpEF, rheumatic fever s/p mechanical MV replacement on warfarin, CAD s/p CABG, CKD3, COPD who presented with worsening SOB and hypoxia in setting of positive COVID test 10 days PTA. She is admitted for acute hypoxic respiratory failure. Also found to have AKI on CKD3 and supratherapeutic INR. Patient's SOB improving with placement on HFNC. Will continue dexamethasone. Hold on remdesivir as pt received monoclonal antibody 2 days PTA and has eGFR < 30. Continue HFNC, wean as tolerated. Supportive care. Give gentle hydration and monitor renal function. Pt given vitamin K in ED, monitor INR. Hold warfarin but plan to resume once INR is at goal range of 2.5-3.5. ASSESSMENT / PLAN: Patient is a 76 y.o. female with a PMHx significant for rheumatic fever s/p mechanical mitral valve replacement on warfarin, HFpEF diastolic dysfunction, CKD III, CABGx1, CAD, HLD, HTN, COPD, CVA, essential tremor, microcytic anemia, hypothyroidism who presents with acute hypoxic respiratory failure in the setting of worsening SOB after positive Covid test 10 days ago.   AHRF Covid-19 pneumonia COPD Exacerbation Worsening SOB, dyspnea and cough, O2 sat 50% on home pulse ox today. Wheezing on exam. satting 91% on 30 L HFNC 60% FIO2.   Plan: -Decadron 6 mg x10 days -O2 supplementation O2 sat goal 90-904% -Albuterol breathing treatment now then 2 puff q 6 -Home Symbicort BID -Continuous pulse ox, tele -Tessalon for cough, saline nasal spray  -If significant O2 desaturation, obtain repeat CXR, D-dimer, consider CTA Progress Note - 1.18.22:  (sedated and intubated) Principal Problem / Chief Complaint Respiratory failure with hypoxia Admitted: 1/6/2022 11:05 AM Length of Stay: 12 days.  Assessment and Plan Patient is a 76 y.o. female PMHx notable for HFpEF, rheumatic fever status post mechanical mitral valve, COPD, CKDIII, CAD s/p CABG x1, hypothyroidism who is admitted to the MICU for further management of acute hypoxic respiratory failure secondary to COVID 19 pneumonia and ARDS.  #  AHRF secondary to COVID-19 pneumonia Hx COPD Symptom onset 12/25, tested positive on 12/26, admitted on 01/06 and intubated 1/10.  Status post monoclonal antibodies on 01/04.  Vaccinated x2 but without booster.  Bronchoscopy with BAL performed 1/10. Negative for legionella and strep. Cultures NGTD. Plan:  o Tapering solumedrol, 30mg x3d (d2) o Lung protective ventilation; ARDS protocol o Completed 5 days Zosyn course o Continue COPD treatment:  Albuterol every 6 hours, Symbicort twice a day, Spiriva daily o Diurese to goal net negative 1L- Lasix 80mg TID o Renal function stable # Leukocytosis  WBC remains elevated but stable.Afebrile overnight with stable map. Continue to watch
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chronic obstructive pulmonary disease, Condition aggravated, Cough, Culture negative, Decreased appetite
Clinical narrative: Hospitalized (1.6.22 - present - currently in ICU);  COVID-19 positive (1.6.22);  fully vaccinated (no booster) Admission date - 1.6.22:  Brief history and medical decision making: 76 y/o F with PMHx of HFpEF, rheumatic fever s/p mechanical MV replacement on warfarin, CAD s/p CABG, CKD3, COPD who presented with worsening SOB and hypoxia in setting of positive COVID test 10 days PTA. She is admitted for acute hypoxic respiratory failure. Also found to have AKI on CKD3 and supratherapeutic INR. Patient's SOB improving with placement on HFNC. Will continue dexamethasone. Hold on remdesivir as pt received monoclonal antibody 2 days PTA and has eGFR < 30. Continue HFNC, wean as tolerated. Supportive care. Give gentle hydration and monitor renal function. Pt given vitamin K in ED, monitor INR. Hold warfarin but plan to resume once INR is at goal range of 2.5-3.5. ASSESSMENT / PLAN: Patient is a 76 y.o. female with a PMHx significant for rheumatic fever s/p mechanical mitral valve replacement on warfarin, HFpEF diastolic dysfunction, CKD III, CABGx1, CAD, HLD, HTN, COPD, CVA, essential tremor, microcytic anemia, hypothyroidism who presents with acute hypoxic respiratory failure in the setting of worsening SOB after positive Covid test 10 days ago.   AHRF Covid-19 pneumonia COPD Exacerbation Worsening SOB, dyspnea and cough, O2 sat 50% on home pulse ox today. Wheezing on exam. satting 91% on 30 L HFNC 60% FIO2.   Plan: -Decadron 6 mg x10 days -O2 supplementation O2 sat goal 90-904% -Albuterol breathing treatment now then 2 puff q 6 -Home Symbicort BID -Continuous pulse ox, tele -Tessalon for cough, saline nasal spray  -If significant O2 desaturation, obtain repeat CXR, D-dimer, consider CTA Progress Note - 1.18.22:  (sedated and intubated) Principal Problem / Chief Complaint Respiratory failure with hypoxia Admitted: 1/6/2022 11:05 AM Length of Stay: 12 days.  Assessment and Plan Patient is a 76 y.o. female PMHx notable for HFpEF, rheumatic fever status post mechanical mitral valve, COPD, CKDIII, CAD s/p CABG x1, hypothyroidism who is admitted to the MICU for further management of acute hypoxic respiratory failure secondary to COVID 19 pneumonia and ARDS.  #  AHRF secondary to COVID-19 pneumonia Hx COPD Symptom onset 12/25, tested positive on 12/26, admitted on 01/06 and intubated 1/10.  Status post monoclonal antibodies on 01/04.  Vaccinated x2 but without booster.  Bronchoscopy with BAL performed 1/10. Negative for legionella and strep. Cultures NGTD. Plan:  o Tapering solumedrol, 30mg x3d (d2) o Lung protective ventilation; ARDS protocol o Completed 5 days Zosyn course o Continue COPD treatment:  Albuterol every 6 hours, Symbicort twice a day, Spiriva daily o Diurese to goal net negative 1L- Lasix 80mg TID o Renal function stable # Leukocytosis  WBC remains elevated but stable.Afebrile overnight with stable map. Continue to watch
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Dyspnoea exertional, Electrocardiogram, Endotracheal intubation, Exposure to SARS-CoV-2
Clinical narrative: Hospitalized (1.6.22 - present - currently in ICU);  COVID-19 positive (1.6.22);  fully vaccinated (no booster) Admission date - 1.6.22:  Brief history and medical decision making: 76 y/o F with PMHx of HFpEF, rheumatic fever s/p mechanical MV replacement on warfarin, CAD s/p CABG, CKD3, COPD who presented with worsening SOB and hypoxia in setting of positive COVID test 10 days PTA. She is admitted for acute hypoxic respiratory failure. Also found to have AKI on CKD3 and supratherapeutic INR. Patient's SOB improving with placement on HFNC. Will continue dexamethasone. Hold on remdesivir as pt received monoclonal antibody 2 days PTA and has eGFR < 30. Continue HFNC, wean as tolerated. Supportive care. Give gentle hydration and monitor renal function. Pt given vitamin K in ED, monitor INR. Hold warfarin but plan to resume once INR is at goal range of 2.5-3.5. ASSESSMENT / PLAN: Patient is a 76 y.o. female with a PMHx significant for rheumatic fever s/p mechanical mitral valve replacement on warfarin, HFpEF diastolic dysfunction, CKD III, CABGx1, CAD, HLD, HTN, COPD, CVA, essential tremor, microcytic anemia, hypothyroidism who presents with acute hypoxic respiratory failure in the setting of worsening SOB after positive Covid test 10 days ago.   AHRF Covid-19 pneumonia COPD Exacerbation Worsening SOB, dyspnea and cough, O2 sat 50% on home pulse ox today. Wheezing on exam. satting 91% on 30 L HFNC 60% FIO2.   Plan: -Decadron 6 mg x10 days -O2 supplementation O2 sat goal 90-904% -Albuterol breathing treatment now then 2 puff q 6 -Home Symbicort BID -Continuous pulse ox, tele -Tessalon for cough, saline nasal spray  -If significant O2 desaturation, obtain repeat CXR, D-dimer, consider CTA Progress Note - 1.18.22:  (sedated and intubated) Principal Problem / Chief Complaint Respiratory failure with hypoxia Admitted: 1/6/2022 11:05 AM Length of Stay: 12 days.  Assessment and Plan Patient is a 76 y.o. female PMHx notable for HFpEF, rheumatic fever status post mechanical mitral valve, COPD, CKDIII, CAD s/p CABG x1, hypothyroidism who is admitted to the MICU for further management of acute hypoxic respiratory failure secondary to COVID 19 pneumonia and ARDS.  #  AHRF secondary to COVID-19 pneumonia Hx COPD Symptom onset 12/25, tested positive on 12/26, admitted on 01/06 and intubated 1/10.  Status post monoclonal antibodies on 01/04.  Vaccinated x2 but without booster.  Bronchoscopy with BAL performed 1/10. Negative for legionella and strep. Cultures NGTD. Plan:  o Tapering solumedrol, 30mg x3d (d2) o Lung protective ventilation; ARDS protocol o Completed 5 days Zosyn course o Continue COPD treatment:  Albuterol every 6 hours, Symbicort twice a day, Spiriva daily o Diurese to goal net negative 1L- Lasix 80mg TID o Renal function stable # Leukocytosis  WBC remains elevated but stable.Afebrile overnight with stable map. Continue to watch
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Glomerular filtration rate decreased, Haemoglobin decreased, Hypotension, Hypoxia, Intensive care
Clinical narrative: Hospitalized (1.6.22 - present - currently in ICU);  COVID-19 positive (1.6.22);  fully vaccinated (no booster) Admission date - 1.6.22:  Brief history and medical decision making: 76 y/o F with PMHx of HFpEF, rheumatic fever s/p mechanical MV replacement on warfarin, CAD s/p CABG, CKD3, COPD who presented with worsening SOB and hypoxia in setting of positive COVID test 10 days PTA. She is admitted for acute hypoxic respiratory failure. Also found to have AKI on CKD3 and supratherapeutic INR. Patient's SOB improving with placement on HFNC. Will continue dexamethasone. Hold on remdesivir as pt received monoclonal antibody 2 days PTA and has eGFR < 30. Continue HFNC, wean as tolerated. Supportive care. Give gentle hydration and monitor renal function. Pt given vitamin K in ED, monitor INR. Hold warfarin but plan to resume once INR is at goal range of 2.5-3.5. ASSESSMENT / PLAN: Patient is a 76 y.o. female with a PMHx significant for rheumatic fever s/p mechanical mitral valve replacement on warfarin, HFpEF diastolic dysfunction, CKD III, CABGx1, CAD, HLD, HTN, COPD, CVA, essential tremor, microcytic anemia, hypothyroidism who presents with acute hypoxic respiratory failure in the setting of worsening SOB after positive Covid test 10 days ago.   AHRF Covid-19 pneumonia COPD Exacerbation Worsening SOB, dyspnea and cough, O2 sat 50% on home pulse ox today. Wheezing on exam. satting 91% on 30 L HFNC 60% FIO2.   Plan: -Decadron 6 mg x10 days -O2 supplementation O2 sat goal 90-904% -Albuterol breathing treatment now then 2 puff q 6 -Home Symbicort BID -Continuous pulse ox, tele -Tessalon for cough, saline nasal spray  -If significant O2 desaturation, obtain repeat CXR, D-dimer, consider CTA Progress Note - 1.18.22:  (sedated and intubated) Principal Problem / Chief Complaint Respiratory failure with hypoxia Admitted: 1/6/2022 11:05 AM Length of Stay: 12 days.  Assessment and Plan Patient is a 76 y.o. female PMHx notable for HFpEF, rheumatic fever status post mechanical mitral valve, COPD, CKDIII, CAD s/p CABG x1, hypothyroidism who is admitted to the MICU for further management of acute hypoxic respiratory failure secondary to COVID 19 pneumonia and ARDS.  #  AHRF secondary to COVID-19 pneumonia Hx COPD Symptom onset 12/25, tested positive on 12/26, admitted on 01/06 and intubated 1/10.  Status post monoclonal antibodies on 01/04.  Vaccinated x2 but without booster.  Bronchoscopy with BAL performed 1/10. Negative for legionella and strep. Cultures NGTD. Plan:  o Tapering solumedrol, 30mg x3d (d2) o Lung protective ventilation; ARDS protocol o Completed 5 days Zosyn course o Continue COPD treatment:  Albuterol every 6 hours, Symbicort twice a day, Spiriva daily o Diurese to goal net negative 1L- Lasix 80mg TID o Renal function stable # Leukocytosis  WBC remains elevated but stable.Afebrile overnight with stable map. Continue to watch
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: International normalised ratio increased, Legionella test, Leukocytosis, Liver function test increased, Mean arterial pressure decreased
Clinical narrative: Hospitalized (1.6.22 - present - currently in ICU);  COVID-19 positive (1.6.22);  fully vaccinated (no booster) Admission date - 1.6.22:  Brief history and medical decision making: 76 y/o F with PMHx of HFpEF, rheumatic fever s/p mechanical MV replacement on warfarin, CAD s/p CABG, CKD3, COPD who presented with worsening SOB and hypoxia in setting of positive COVID test 10 days PTA. She is admitted for acute hypoxic respiratory failure. Also found to have AKI on CKD3 and supratherapeutic INR. Patient's SOB improving with placement on HFNC. Will continue dexamethasone. Hold on remdesivir as pt received monoclonal antibody 2 days PTA and has eGFR < 30. Continue HFNC, wean as tolerated. Supportive care. Give gentle hydration and monitor renal function. Pt given vitamin K in ED, monitor INR. Hold warfarin but plan to resume once INR is at goal range of 2.5-3.5. ASSESSMENT / PLAN: Patient is a 76 y.o. female with a PMHx significant for rheumatic fever s/p mechanical mitral valve replacement on warfarin, HFpEF diastolic dysfunction, CKD III, CABGx1, CAD, HLD, HTN, COPD, CVA, essential tremor, microcytic anemia, hypothyroidism who presents with acute hypoxic respiratory failure in the setting of worsening SOB after positive Covid test 10 days ago.   AHRF Covid-19 pneumonia COPD Exacerbation Worsening SOB, dyspnea and cough, O2 sat 50% on home pulse ox today. Wheezing on exam. satting 91% on 30 L HFNC 60% FIO2.   Plan: -Decadron 6 mg x10 days -O2 supplementation O2 sat goal 90-904% -Albuterol breathing treatment now then 2 puff q 6 -Home Symbicort BID -Continuous pulse ox, tele -Tessalon for cough, saline nasal spray  -If significant O2 desaturation, obtain repeat CXR, D-dimer, consider CTA Progress Note - 1.18.22:  (sedated and intubated) Principal Problem / Chief Complaint Respiratory failure with hypoxia Admitted: 1/6/2022 11:05 AM Length of Stay: 12 days.  Assessment and Plan Patient is a 76 y.o. female PMHx notable for HFpEF, rheumatic fever status post mechanical mitral valve, COPD, CKDIII, CAD s/p CABG x1, hypothyroidism who is admitted to the MICU for further management of acute hypoxic respiratory failure secondary to COVID 19 pneumonia and ARDS.  #  AHRF secondary to COVID-19 pneumonia Hx COPD Symptom onset 12/25, tested positive on 12/26, admitted on 01/06 and intubated 1/10.  Status post monoclonal antibodies on 01/04.  Vaccinated x2 but without booster.  Bronchoscopy with BAL performed 1/10. Negative for legionella and strep. Cultures NGTD. Plan:  o Tapering solumedrol, 30mg x3d (d2) o Lung protective ventilation; ARDS protocol o Completed 5 days Zosyn course o Continue COPD treatment:  Albuterol every 6 hours, Symbicort twice a day, Spiriva daily o Diurese to goal net negative 1L- Lasix 80mg TID o Renal function stable # Leukocytosis  WBC remains elevated but stable.Afebrile overnight with stable map. Continue to watch
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mechanical ventilation, Oxygen saturation decreased, Packed red blood cell transfusion, Renal function test, Respiratory distress
Clinical narrative: Hospitalized (1.6.22 - present - currently in ICU);  COVID-19 positive (1.6.22);  fully vaccinated (no booster) Admission date - 1.6.22:  Brief history and medical decision making: 76 y/o F with PMHx of HFpEF, rheumatic fever s/p mechanical MV replacement on warfarin, CAD s/p CABG, CKD3, COPD who presented with worsening SOB and hypoxia in setting of positive COVID test 10 days PTA. She is admitted for acute hypoxic respiratory failure. Also found to have AKI on CKD3 and supratherapeutic INR. Patient's SOB improving with placement on HFNC. Will continue dexamethasone. Hold on remdesivir as pt received monoclonal antibody 2 days PTA and has eGFR < 30. Continue HFNC, wean as tolerated. Supportive care. Give gentle hydration and monitor renal function. Pt given vitamin K in ED, monitor INR. Hold warfarin but plan to resume once INR is at goal range of 2.5-3.5. ASSESSMENT / PLAN: Patient is a 76 y.o. female with a PMHx significant for rheumatic fever s/p mechanical mitral valve replacement on warfarin, HFpEF diastolic dysfunction, CKD III, CABGx1, CAD, HLD, HTN, COPD, CVA, essential tremor, microcytic anemia, hypothyroidism who presents with acute hypoxic respiratory failure in the setting of worsening SOB after positive Covid test 10 days ago.   AHRF Covid-19 pneumonia COPD Exacerbation Worsening SOB, dyspnea and cough, O2 sat 50% on home pulse ox today. Wheezing on exam. satting 91% on 30 L HFNC 60% FIO2.   Plan: -Decadron 6 mg x10 days -O2 supplementation O2 sat goal 90-904% -Albuterol breathing treatment now then 2 puff q 6 -Home Symbicort BID -Continuous pulse ox, tele -Tessalon for cough, saline nasal spray  -If significant O2 desaturation, obtain repeat CXR, D-dimer, consider CTA Progress Note - 1.18.22:  (sedated and intubated) Principal Problem / Chief Complaint Respiratory failure with hypoxia Admitted: 1/6/2022 11:05 AM Length of Stay: 12 days.  Assessment and Plan Patient is a 76 y.o. female PMHx notable for HFpEF, rheumatic fever status post mechanical mitral valve, COPD, CKDIII, CAD s/p CABG x1, hypothyroidism who is admitted to the MICU for further management of acute hypoxic respiratory failure secondary to COVID 19 pneumonia and ARDS.  #  AHRF secondary to COVID-19 pneumonia Hx COPD Symptom onset 12/25, tested positive on 12/26, admitted on 01/06 and intubated 1/10.  Status post monoclonal antibodies on 01/04.  Vaccinated x2 but without booster.  Bronchoscopy with BAL performed 1/10. Negative for legionella and strep. Cultures NGTD. Plan:  o Tapering solumedrol, 30mg x3d (d2) o Lung protective ventilation; ARDS protocol o Completed 5 days Zosyn course o Continue COPD treatment:  Albuterol every 6 hours, Symbicort twice a day, Spiriva daily o Diurese to goal net negative 1L- Lasix 80mg TID o Renal function stable # Leukocytosis  WBC remains elevated but stable.Afebrile overnight with stable map. Continue to watch
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiratory failure, SARS-CoV-2 test positive, Streptococcus test negative, Therapy change, Wheezing
Clinical narrative: Hospitalized (1.6.22 - present - currently in ICU);  COVID-19 positive (1.6.22);  fully vaccinated (no booster) Admission date - 1.6.22:  Brief history and medical decision making: 76 y/o F with PMHx of HFpEF, rheumatic fever s/p mechanical MV replacement on warfarin, CAD s/p CABG, CKD3, COPD who presented with worsening SOB and hypoxia in setting of positive COVID test 10 days PTA. She is admitted for acute hypoxic respiratory failure. Also found to have AKI on CKD3 and supratherapeutic INR. Patient's SOB improving with placement on HFNC. Will continue dexamethasone. Hold on remdesivir as pt received monoclonal antibody 2 days PTA and has eGFR < 30. Continue HFNC, wean as tolerated. Supportive care. Give gentle hydration and monitor renal function. Pt given vitamin K in ED, monitor INR. Hold warfarin but plan to resume once INR is at goal range of 2.5-3.5. ASSESSMENT / PLAN: Patient is a 76 y.o. female with a PMHx significant for rheumatic fever s/p mechanical mitral valve replacement on warfarin, HFpEF diastolic dysfunction, CKD III, CABGx1, CAD, HLD, HTN, COPD, CVA, essential tremor, microcytic anemia, hypothyroidism who presents with acute hypoxic respiratory failure in the setting of worsening SOB after positive Covid test 10 days ago.   AHRF Covid-19 pneumonia COPD Exacerbation Worsening SOB, dyspnea and cough, O2 sat 50% on home pulse ox today. Wheezing on exam. satting 91% on 30 L HFNC 60% FIO2.   Plan: -Decadron 6 mg x10 days -O2 supplementation O2 sat goal 90-904% -Albuterol breathing treatment now then 2 puff q 6 -Home Symbicort BID -Continuous pulse ox, tele -Tessalon for cough, saline nasal spray  -If significant O2 desaturation, obtain repeat CXR, D-dimer, consider CTA Progress Note - 1.18.22:  (sedated and intubated) Principal Problem / Chief Complaint Respiratory failure with hypoxia Admitted: 1/6/2022 11:05 AM Length of Stay: 12 days.  Assessment and Plan Patient is a 76 y.o. female PMHx notable for HFpEF, rheumatic fever status post mechanical mitral valve, COPD, CKDIII, CAD s/p CABG x1, hypothyroidism who is admitted to the MICU for further management of acute hypoxic respiratory failure secondary to COVID 19 pneumonia and ARDS.  #  AHRF secondary to COVID-19 pneumonia Hx COPD Symptom onset 12/25, tested positive on 12/26, admitted on 01/06 and intubated 1/10.  Status post monoclonal antibodies on 01/04.  Vaccinated x2 but without booster.  Bronchoscopy with BAL performed 1/10. Negative for legionella and strep. Cultures NGTD. Plan:  o Tapering solumedrol, 30mg x3d (d2) o Lung protective ventilation; ARDS protocol o Completed 5 days Zosyn course o Continue COPD treatment:  Albuterol every 6 hours, Symbicort twice a day, Spiriva daily o Diurese to goal net negative 1L- Lasix 80mg TID o Renal function stable # Leukocytosis  WBC remains elevated but stable.Afebrile overnight with stable map. Continue to watch
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: White blood cell count increased
Clinical narrative: Hospitalized (1.6.22 - present - currently in ICU);  COVID-19 positive (1.6.22);  fully vaccinated (no booster) Admission date - 1.6.22:  Brief history and medical decision making: 76 y/o F with PMHx of HFpEF, rheumatic fever s/p mechanical MV replacement on warfarin, CAD s/p CABG, CKD3, COPD who presented with worsening SOB and hypoxia in setting of positive COVID test 10 days PTA. She is admitted for acute hypoxic respiratory failure. Also found to have AKI on CKD3 and supratherapeutic INR. Patient's SOB improving with placement on HFNC. Will continue dexamethasone. Hold on remdesivir as pt received monoclonal antibody 2 days PTA and has eGFR < 30. Continue HFNC, wean as tolerated. Supportive care. Give gentle hydration and monitor renal function. Pt given vitamin K in ED, monitor INR. Hold warfarin but plan to resume once INR is at goal range of 2.5-3.5. ASSESSMENT / PLAN: Patient is a 76 y.o. female with a PMHx significant for rheumatic fever s/p mechanical mitral valve replacement on warfarin, HFpEF diastolic dysfunction, CKD III, CABGx1, CAD, HLD, HTN, COPD, CVA, essential tremor, microcytic anemia, hypothyroidism who presents with acute hypoxic respiratory failure in the setting of worsening SOB after positive Covid test 10 days ago.   AHRF Covid-19 pneumonia COPD Exacerbation Worsening SOB, dyspnea and cough, O2 sat 50% on home pulse ox today. Wheezing on exam. satting 91% on 30 L HFNC 60% FIO2.   Plan: -Decadron 6 mg x10 days -O2 supplementation O2 sat goal 90-904% -Albuterol breathing treatment now then 2 puff q 6 -Home Symbicort BID -Continuous pulse ox, tele -Tessalon for cough, saline nasal spray  -If significant O2 desaturation, obtain repeat CXR, D-dimer, consider CTA Progress Note - 1.18.22:  (sedated and intubated) Principal Problem / Chief Complaint Respiratory failure with hypoxia Admitted: 1/6/2022 11:05 AM Length of Stay: 12 days.  Assessment and Plan Patient is a 76 y.o. female PMHx notable for HFpEF, rheumatic fever status post mechanical mitral valve, COPD, CKDIII, CAD s/p CABG x1, hypothyroidism who is admitted to the MICU for further management of acute hypoxic respiratory failure secondary to COVID 19 pneumonia and ARDS.  #  AHRF secondary to COVID-19 pneumonia Hx COPD Symptom onset 12/25, tested positive on 12/26, admitted on 01/06 and intubated 1/10.  Status post monoclonal antibodies on 01/04.  Vaccinated x2 but without booster.  Bronchoscopy with BAL performed 1/10. Negative for legionella and strep. Cultures NGTD. Plan:  o Tapering solumedrol, 30mg x3d (d2) o Lung protective ventilation; ARDS protocol o Completed 5 days Zosyn course o Continue COPD treatment:  Albuterol every 6 hours, Symbicort twice a day, Spiriva daily o Diurese to goal net negative 1L- Lasix 80mg TID o Renal function stable # Leukocytosis  WBC remains elevated but stable.Afebrile overnight with stable map. Continue to watch
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Chills, Gingival bleeding, Gingival blister, Gingival pain
Clinical narrative: 2 days following I had a headache for 4 days, then following that I had sore, bleeding gums that became full blisters inside my mouth by the following morning when I woke. I had chills as well but the mouth sores were what sent me to the doctor. I also had gingivitis come about which I have never had.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Stomatitis
Clinical narrative: 2 days following I had a headache for 4 days, then following that I had sore, bleeding gums that became full blisters inside my mouth by the following morning when I woke. I had chills as well but the mouth sores were what sent me to the doctor. I also had gingivitis come about which I have never had.
Age: 17.0
Sex: F
Vaccine: UNK
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was given a Moderna booster- Patient not eligable for moderna due to age. No symptoms
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Cold sweat, Cyanosis, Dysstasia
Clinical narrative: He got his vaccine, a couple of days went by and seemed okay.  He then complained of having no energy, had difficulty getting up and was kind of clammy and bluish.  The next morning they took him to the Hospital and was diagnosed with COVID.  He was in the hospital a couple of weeks, and then was discharged.  He went to the temporary care unit.  He has recovered and doing OK.  He did have to build his strength back up following COVID.    He received 75% oxygen and they thought that he would not make it, but he has survived and improving.  He did have PT to build his strength and continues to improve.    He thinks that the booster gave him COVID.  Son talked to the pharmacist and told him that was not possible.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: No adverse reaction noted
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: tinnitus.  Please note I do not know the exact day it started - he just said "after" the vaccine, but I couldn't complete the form without putting in a date. Patient reports the tinnitus has not resolved since then.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Mental status changes
Clinical narrative: Rigors, worsening altered mental status
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Pt fully vaccinated for COVID with Pfizer. Unknown dates of vaccinations. Tested positive for COVID upon admission to hospital.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Left arm where the shot was given is terribly sore weeks and weeks after the shot.  I can hardly raise it up any more.  It keeps getting worse although I stretch it and try to rub it out.  I keep hoping it'll go away and my employer is talking about booster shots now.  I don't want another vaccine.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Aggression, Agitation, COVID-19, Confusional state
Clinical narrative: pt to ED after recent hospitalization for COVID AND NSTEMI; had been dc'd to home with O2 supplementation; to ED with c/o increasing SOB, persistent confusion, increased O2 requirements; pt is positive for COVID in ED; treated with decadron and remdesivir; NRB mask; pt became more confused, agitated and combative; pulling O2 mask off and O2 sats decreasing; nurse found pt to be unresponsive and CPR was started and continued for 15 minutes; pt's family decided to stop compressions and make pt a DNI; pt died in the hospital
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Dyspnoea, Oxygen saturation decreased, Resuscitation, SARS-CoV-2 test positive
Clinical narrative: pt to ED after recent hospitalization for COVID AND NSTEMI; had been dc'd to home with O2 supplementation; to ED with c/o increasing SOB, persistent confusion, increased O2 requirements; pt is positive for COVID in ED; treated with decadron and remdesivir; NRB mask; pt became more confused, agitated and combative; pulling O2 mask off and O2 sats decreasing; nurse found pt to be unresponsive and CPR was started and continued for 15 minutes; pt's family decided to stop compressions and make pt a DNI; pt died in the hospital
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Unresponsive to stimuli
Clinical narrative: pt to ED after recent hospitalization for COVID AND NSTEMI; had been dc'd to home with O2 supplementation; to ED with c/o increasing SOB, persistent confusion, increased O2 requirements; pt is positive for COVID in ED; treated with decadron and remdesivir; NRB mask; pt became more confused, agitated and combative; pulling O2 mask off and O2 sats decreasing; nurse found pt to be unresponsive and CPR was started and continued for 15 minutes; pt's family decided to stop compressions and make pt a DNI; pt died in the hospital
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: My left shoulder & arm were in intense pain! It started the  night the vaccine was given. I continued until Dec 15,2021 after I had an injection in my back to relieve the pain. The injection was given by the doctor on Dec 14,2021. It has begun to be very painful again on Jan 9,2022.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood test, COVID-19, Chills, Ear pain
Clinical narrative: 1st vaccine- 1/14/2021?.. 2nd dose 2/11/2021?. Booster dose.  10/25/2021 I had a breakthrough case from December 31,  2021 thru January 6, 2022 Symptoms: severe headache first night, severe stabbing pain in right ear for four days, lethargic and weak for first three days which I slept day and night.  Chills, shaking uncontrollably fir one hour- no fever.  Unable to eat due to sleeping and nausea, contacted my PA on day 3 1/2 and was ordered to take, ampicillin 850mgm BID for ten days and a round of steroids for 6 days. I lost 9 pounds in the first four days.  My PA sent me to a tent testing site on day 5 and came back negative- I then took a take at home rapid test which also came back negative.   When I was able to eat on day 5 my taste was ?weird? ?blueberries tasted like perfume, carrot soup tasted like liquid mashed potatoes but the spice ( ginger) burned my throat and I could not taste the ginger.  I had no sore throat during the whole time.  It took seven days for my food to taste normal.  I went to see my PA on day 12 and because of my symptoms and two negative tests she had me get an IGG titer  bloodwork for COVID antibodies?? she called is less than 24 hours to tell me I had had COVID.  I had my two initial vaccines and my booster and I am very strict with masks and sanitizers